Phentermine is approved only for short-term use (up to 12 weeks), whereas modern GLP-1 therapy like semaglutide supports long-term weight management
Naltrexone with bupropion
Many patients restart them postpartum, after finishing breastfeeding, as part of long-term weight management
[1] [2] It does not hold a marketing authorisation from the MHRA or EMA, and is therefore only available through approved clinical trials or, in exceptional circumstances, via a regulated NHS specials supply route
At Set Point Medical Weight Loss Clinic, we can help you understand the potential benefits and drawbacks of GLP-1 agonists and other weight management strategies
On the body, the combination of muscle and fat loss leaves skin without adequate supportwhich is why many people notice sagging in the arms, abdomen, and thighs even at their goal weight